Steven Echard, CAE - Executive Vice President of American College of Rheumatology @acrheum - Empowering Rheum Professionals to excel in their specialty #ACR24
Traveling internationally to #ACR26? 🧳 ACR Convergence 2026 is Nov. 6–11 in Orlando—now’s the time to prepare your visa & invitation letter. ACR makes it easy! GET STARTED → https://t.co/1dTpdjPtM6
Still TIME to register for the ACR Convergence Replay 2025: Secrets & Pearls of Rheumatology LIVE webinar on Tues., Dec. 9, at 7:00 PM ET. ⏱️ Explore expert tips & strategies on #lupus, connective tissue disorders, & complex autoimmunity.
ACR/ARP members get a discount. Already attended #ACR25? You have access! SECURE YOUR SPOT → https://t.co/3tP5Ddmgjv
FREE ACR Rheumatology Virtual Grand Rounds! Bring high-quality #rheum education straight to your residency program.
📚 27 recorded didactic sessions with synced slides + embedded assessments
🎓 Free, open access for residency programs
🩺 No rheumatologist on staff? No problem. Get expert explanations & ready-to-use content.
Explore both adult & pediatric #rheum modules today! 🔎
Adult: https://t.co/5xfaMZx8FY
Pediatric: https://t.co/BbqU5BO6CI
More news from #ACR25: new & updated ACR guidelines, managing #SLE during pregnancy, new insights into #ILD management, & advances in #GCA—this week in The #Rheumatologist.
▶️ https://t.co/2SpTSGcD3F
Join us Tues., Dec. 9, at 7:00 PM ET for the ACR Convergence Replay 2025: Secrets & Pearls of Rheumatology LIVE webinar. Explore expert tips & strategies on #lupus, connective tissue disorders, & complex autoimmunity. 💡
ACR/ARP members get a discount. Already attended #ACR25? You have access! REGISTER TODAY → https://t.co/3tP5Ddmgjv
If you’re not following the #ACR25#ACRambassador team, you’re missing all the best meeting updates! 📣 Stay in the know—these #rheum influencers have the inside scoop on everything #ACR25 → https://t.co/3gkkdTiLh3
Kudos to this year’s recipients of the ACR Master designation, one of the highest honors bestowed by the College. 👏 Masters → https://t.co/nhbPX83RI8 #ACR25
NEW #SLE clinical practice guideline to be unveiled at #ACR25! ✨
Don’t miss this important session—2025 American College of Rheumatology Guideline for the Treatment of Systemic Lupus Erythematosus, Saturday, Oct. 26, 9:00-10:30 AM CT. DETAILS → https://t.co/fayutXpTH0
COMING SOON: Full guideline manuscript. Stay tuned 👀 → https://t.co/vVRcKYssrb
What can you expect from the #ACR25 Basic and Clinical Research Conference?
🔗 Find out from the conference co-chairs in ACR Convergence Today → https://t.co/mtnrxGCMO7
More companies are choosing to partner with the Rheumatology Research Foundation to invest in the future of rheumatology. Corporate supporters are aligning their contributions with long-term impact—helping to improve the lives of millions affected by rheumatic diseases by investing in innovative research and initiatives that will bolster the rheumatology workforce.
Learn why corporations are investing in the future of rheumatology in the latest issue of Foundation Voice: https://t.co/VC7uGgWqnM
Submit your #ACR25 late-breaking abstract by TOMORROW, Thurs., Sept. 11, at noon ET. Don’t miss the chance to share your expertise on high-impact research! Details → https://t.co/ORO51zhmKF
We've waited, hoping responsible leaders would make the right decisions. Now, it's time to advocate for the actions that science demands."
@ACRheum@ACRheumDC
The ACR is deeply concerned about recent CDC changes that threaten science-based vaccine policy. Immunocompromised patients rely on expert guidance. We urge transparency and oversight. Read our statement: https://t.co/zc5xyHztBs #publichealth#vaccines#rheumatology
The ACR is deeply concerned about recent CDC changes that threaten science-based vaccine policy. Immunocompromised patients rely on expert guidance. We urge transparency and oversight. Read our statement: https://t.co/zc5xyHztBs #publichealth#vaccines#rheumatology
NOW OPEN: 2026 ILAR call for project proposals that advance #rheum in developing countries in the areas of patient/health professional education including population health and/or clinical practice & advocacy for #rheum. Deadline Sept. 15, 2025. Details → https://t.co/DAPuO3lyMc
Analysis of whole-exome seq data from MyCode & BioMe biobanks investigated assoc between UBA1 VAF and VEXAS disease manif. Results showed ↑VAF resulted in more severe disease & higher penetrance, while ↓VAF had incomplete penetrance & milder disease
A&R
https://t.co/zETS4x7xfl
Can early intervention reshape the future of Sjögren’s care? Dr. Dana DiRenzo explores this critical question & more in our latest episode on novel therapies and trial data. TUNE IN → https://t.co/TRi6GrESD3
I spent the day advocating for arthritis with three of the best advocates with @ACRheumDC. Thank you @ExuberantExudat@PRheumdoc and Dr. Hermine Brunner for your expertise and compassion for your patients. #Act4Arthritis